nivolumab
bms
['check,mate,816', 'checkmate-816', 'increase,(-increased)']
increase: single arm phase 2
operable (after neoadj) t3-4n0-2m0 -&gt; neoadjuvant io/chemort -&gt; surgery pcr 63% , compare to checkmate-816 24% interesting cd8+ t cell responses #esmo2022 #radonc 